These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37495200)
1. Association of Renin-Angiotensin System Inhibition With Liver-Related Events and Mortality in Compensated Cirrhosis. Elhence H; Dodge JL; Lee BP Clin Gastroenterol Hepatol; 2024 Feb; 22(2):315-323.e17. PubMed ID: 37495200 [TBL] [Abstract][Full Text] [Related]
2. The Association Between Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Exposure and Key Cirrhosis-Related Outcomes. Wang RX; Serper M; Taddei TH; Kaplan DE; Mahmud N Am J Gastroenterol; 2024 Jul; ():. PubMed ID: 39051649 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease. Zhang X; Wong GL; Yip TC; Tse YK; Liang LY; Hui VW; Lin H; Li GL; Lai JC; Chan HL; Wong VW Hepatology; 2022 Aug; 76(2):469-482. PubMed ID: 34939204 [TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study. Shen JI; Saxena AB; Vangala S; Dhaliwal SK; Winkelmayer WC BMC Nephrol; 2017 Jun; 18(1):196. PubMed ID: 28623899 [TBL] [Abstract][Full Text] [Related]
5. Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study. Christiansen CF; Heide-Jørgensen U; Rasmussen TB; Bodilsen J; Søgaard OS; Maeng M; Vistisen ST; Schmidt M; Pottegård A; Lund LC; Reilev M; Hallas J; Johansen NB; Brun NC; Sørensen HT; Thomsen RW J Am Heart Assoc; 2020 Oct; 9(19):e017297. PubMed ID: 32998607 [TBL] [Abstract][Full Text] [Related]
6. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. ; Lawler PR; Derde LPG; van de Veerdonk FL; McVerry BJ; Huang DT; Berry LR; Lorenzi E; van Kimmenade R; Gommans F; Vaduganathan M; Leaf DE; Baron RM; Kim EY; Frankfurter C; Epelman S; Kwan Y; Grieve R; O'Neill S; Sadique Z; Puskarich M; Marshall JC; Higgins AM; Mouncey PR; Rowan KM; Al-Beidh F; Annane D; Arabi YM; Au C; Beane A; van Bentum-Puijk W; Bonten MJM; Bradbury CA; Brunkhorst FM; Burrell A; Buzgau A; Buxton M; Cecconi M; Cheng AC; Cove M; Detry MA; Estcourt LJ; Ezekowitz J; Fitzgerald M; Gattas D; Godoy LC; Goossens H; Haniffa R; Harrison DA; Hills T; Horvat CM; Ichihara N; Lamontagne F; Linstrum KM; McAuley DF; McGlothlin A; McGuinness SP; McQuilten Z; Murthy S; Nichol AD; Owen DRJ; Parke RL; Parker JC; Pollock KM; Reyes LF; Saito H; Santos MS; Saunders CT; Seymour CW; Shankar-Hari M; Singh V; Turgeon AF; Turner AM; Zarychanski R; Green C; Lewis RJ; Angus DC; Berry S; Gordon AC; McArthur CJ; Webb SA JAMA; 2023 Apr; 329(14):1183-1196. PubMed ID: 37039790 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses. Catalá-López F; Macías Saint-Gerons D; González-Bermejo D; Rosano GM; Davis BR; Ridao M; Zaragoza A; Montero-Corominas D; Tobías A; de la Fuente-Honrubia C; Tabarés-Seisdedos R; Hutton B PLoS Med; 2016 Mar; 13(3):e1001971. PubMed ID: 26954482 [TBL] [Abstract][Full Text] [Related]
8. Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors. Eworuke E; Welch EC; Haug N; Horgan C; Lee HS; Zhao Y; Huang TY J Am Coll Cardiol; 2023 Jan; 81(4):321-331. PubMed ID: 36697132 [TBL] [Abstract][Full Text] [Related]
9. Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices. Converse MP; Sobhanian M; Taber DJ; Houston BA; Meadows HB; Uber WE J Am Coll Cardiol; 2019 Apr; 73(14):1769-1778. PubMed ID: 30975293 [TBL] [Abstract][Full Text] [Related]
10. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia. Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093 [TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system blockers and 1-year mortality in patients with post-operative acute kidney injury. Slagelse C; Gammelager H; Iversen LH; Liu KD; Sørensen HT; Christiansen CF Acta Anaesthesiol Scand; 2020 Oct; 64(9):1262-1269. PubMed ID: 32557539 [TBL] [Abstract][Full Text] [Related]
12. Risk of Viral Infection in Patients Using Either Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers: A Nationwide Population-based Propensity Score Matching Study. Lin SY; Ju SW; Lin CL; Lin CC; Hsu WH; Chou CH; Chi CY; Hsu CY; Kao CH Clin Infect Dis; 2020 Dec; 71(10):2695-2701. PubMed ID: 32504531 [TBL] [Abstract][Full Text] [Related]
13. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate. Qiao Y; Shin JI; Chen TK; Inker LA; Coresh J; Alexander GC; Jackson JW; Chang AR; Grams ME JAMA Intern Med; 2020 May; 180(5):718-726. PubMed ID: 32150237 [TBL] [Abstract][Full Text] [Related]
14. Preadmission use of renin-angiotensin blockers and rupture of abdominal aortic aneurysm: a nationwide, population-based study. Wemmelund H; Høgh A; Hundborg HH; Johnsen SP; Lindholt JS Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):141-50. PubMed ID: 26817783 [TBL] [Abstract][Full Text] [Related]
15. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
16. Adverse impact of renin-angiotensin system blockade on the clinical course in hospitalized patients with severe COVID-19: a retrospective cohort study. Lim JH; Cho JH; Jeon Y; Kim JH; Lee GY; Jeon S; Noh HW; Lee YH; Lee J; Chang HH; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Kim SW Sci Rep; 2020 Nov; 10(1):20250. PubMed ID: 33219294 [TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea. Lee J; Lee S Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. Derington CG; Cohen JB; Mohanty AF; Greene TH; Cook J; Ying J; Wei G; Herrick JS; Stevens VW; Jones BE; Wang L; Zheutlin AR; South AM; Hanff TC; Smith SM; Cooper-DeHoff RM; King JB; Alexander GC; Berlowitz DR; Ahmad FS; Penrod MJ; Hess R; Conroy MB; Fang JC; Rubin MA; Beddhu S; Cheung AK; Xian W; Weintraub WS; Bress AP PLoS One; 2021; 16(4):e0248080. PubMed ID: 33891615 [TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis. Wu CK; Yang YH; Juang JJ; Wang YC; Tsai CT; Lai LP; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY Medicine (Baltimore); 2015 Jan; 94(3):e424. PubMed ID: 25621694 [TBL] [Abstract][Full Text] [Related]
20. Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality After Sepsis: A Population-Based Cohort Study. Hsu WT; Galm BP; Schrank G; Hsu TC; Lee SH; Park JY; Lee CC Hypertension; 2020 Feb; 75(2):483-491. PubMed ID: 31838905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]